MedServ Group, Inc. – Trademark Portfolio

Entity Type: 03

MedServ Group, Inc. holds 37 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 36 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 8 trademarks are registered. Notable registered marks include BIOMED, GV 350, BIOSTIM, MEDSERV, and REBOUND. The owner is based in Vista, CA.

PO Box 1360

Vista, CA 92085

37 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Page 1 of 2 (37 results)

Trademark Classifications

MedServ Group, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (36 filings)

Surgical, medical, dental and veterinary apparatus and instruments

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does MedServ Group, Inc. have?

MedServ Group, Inc. has 37 U.S. trademarks filed with the USPTO. Of these, 8 registered, 4 abandoned, 25 cancelled.

What trademark classes does MedServ Group, Inc. file in?

MedServ Group, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are MedServ Group, Inc.'s most well-known trademarks?

MedServ Group, Inc.'s registered trademark portfolio includes well-known marks such as BIOMED, GV 350, BIOSTIM, MEDSERV, and REBOUND. These are among 8 currently registered trademarks in the portfolio.

What is MedServ Group, Inc.'s trademark registration success rate?

MedServ Group, Inc. has a 22% trademark registration rate, with 8 out of 37 resolved applications resulting in successful registration. Currently, 0 applications are pending review.